What risk-enhancing factors are useful for those at intermediate risk?
Knowledge of risk-enhancing factors such as metabolic syndrome, inflammatory diseases, such as psoriasis and rheumatoid arthritis, and HIV when treated with protease, are useful for all individuals, but particularly for those at intermediate risk (ASCVD risk of 7.5% to 20%).